Loma Linda, CA4 Active Studies

Ankylosing Spondylitis Clinical Trials in Loma Linda, CA

Find 4 actively recruiting ankylosing spondylitis clinical trials in Loma Linda, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
7,930
Enrolling

Recruiting Ankylosing Spondylitis Studies in Loma Linda

About Ankylosing Spondylitis Clinical Trials in Loma Linda

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Loma Linda, CA. These studies are seeking a combined 7,930 participants. Research is being sponsored by University of California, San Francisco, Genzyme, a Sanofi Company, Children's Oncology Group and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Loma Linda — FAQ

Are there ankylosing spondylitis clinical trials in Loma Linda?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Loma Linda, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Loma Linda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Loma Linda research site will contact you about next steps.

Are clinical trials in Loma Linda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Loma Linda studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in Loma Linda are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 17, 2026 from ClinicalTrials.gov